Voyager Technologies and Exobiosphere partner for ISS drug screening mission.

{
  "signal_id": "e506462a-89df-4e8e-b469-e000af87e2da",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-05-13T15:03:23+00:00",
  "company": {
    "name": "Voyager Technologies",
    "domain": "voyagertechnologies.com"
  },
  "data": {
    "url": "https://www.wftv.com/news/local/voyager-technologies-exobiosphere-partner-iss-drug-screening-mission/4CNY34EABJAFZNBRBE4SOURJPE",
    "title": "Voyager Technologies and Exobiosphere partner for ISS drug screening mission.",
    "ticker": "NYSE:VOYG",
    "excerpt": "Voyager Technologies and Exobiosphere partner for ISS drug screening mission.\n\nMay 13, 2026 at 11:03 am EDT\n\nORLANDO, Fla. - Voyager Technologies and Exobiosphere are partnering on a new mission aboard the International Space Station aimed at making automated biological research in microgravity more accessible.\n\nThe companies announced a mission management contract for Exobiosphere's Orbital High-Throughput Screener, a miniaturized platform designed to run automated drug-screening experiments in orbit.\n\nVoyager Technologies Europe will serve as mission integrator for the payload. The company said it will provide project management support, safety and verification work under NASA Safety Review standards, integration aboard the ISS and coordination of on-orbit operations.\n\n\"Our mission management services exist to build a clear path for innovative ideas to become a reality in space,\" said Matt Magaña, president of space, defense and national security at Voyager. \"Facilitating this access to the ISS is critical to improving life here on Earth.\"\n\nExobiosphere said the platform is designed for repeat use, allowing samples and consumable elements to be exchanged between campaigns. The company said that would allow pharmaceutical and biotech clients to run a continuous pipeline of experiments without needing new hardware deployed each time.\n\n\"OHTS is the first payload of its kind...",
    "summary": "Voyager Space Company partners with Exobiosphere SARL.",
    "location": "Orlando, Florida, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://cmg-cmg-tv-10070-prod.cdn.arcpublishing.com/resizer/v2/https%3A%2F%2Fcloudfront-us-east-1.images.arcpublishing.com%2Fcmg%2FQAINMTOI7VDMBFDG535WJJ76KI.jpg?auth=1ced2069d52f219934f5987bfb1513b37d3e626ad450cc2ad807685947a093e9&width=1200&height=630&smart=true",
    "confidence": 0.3376,
    "published_at": "2026-05-13T15:03:23Z",
    "location_data": [
      {
        "city": "Orlando",
        "state": "Florida",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "Voyager Technologies and Exobiosphere partner for ISS drug screening mission.",
    "related_company_name": "Exobiosphere SARL",
    "related_company_domain": "exobiosphere.com"
  }
}

curl https://signals.autobound.ai/v1/signals/e506462a-89df-4e8e-b469-e000af87e2da \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"voyagertechnologies.com","limit":20}'